Cost-effectiveness of capecitabine and bevacizumab maintenance treatment after first-line induction treatment in metastatic colorectal cancer

Autor: A.J. ten Tije, M Franken, E.M. van Rooijen, B.C. Tanis, Linda Mol, Miriam Koopman, C.A. Uyl-de Groot, Anne M. May, C.J.A. Punt, G.J.M. Creemers, A.M.T. van der Velden, M. G. H. van Oijen, Hendrik Koffijberg, H. van Tinteren

Publikováno v: European journal of cancer (Oxford, England, 75, 204-212. Elsevier Limited
European Journal of Cancer, 75, 204-212. Elsevier Ltd.
European Journal of Cancer, 75, 204. Elsevier Limited

Aim Capecitabine and bevacizumab (CAP-B) maintenance therapy has shown to be more effective compared with observation in metastatic colorectal cancer patients achieving stable disease or better after six cycles of first-line capecitabine, oxaliplatin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a56c69a66a6cdca321f65ce68b666f3
https://dspace.library.uu.nl/handle/1874/350448

PCN196 Review of Cost Effectiveness of Trastuzumab in Early Breast Cancer

Autor: Marieke Krol, E.M. Van rooijen

Publikováno v: Value in Health. 14(7)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee1af151f62b42d429871e146c93563d

2119 Capecitabine and bevacizumab (CB) maintenance treatment in metastatic colorectal cancer (mCRC): A cost-effectiveness analysis

Autor: M Franken, A.M.T. van der Velden, A.J. ten Tije, E.M. van Rooijen, A. M. May, G.J.M. Creemers, M. Koopman, C.J.A. Punt, H. van Tinteren, Linda Mol, M. G. H. van Oijen, A. Van derTorren, C.A. Uyl-de Groot

Publikováno v: European Journal of Cancer. 51:S370

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4cb5eba3b17c07efd8970af1eae3be5b
https://doi.org/10.1016/s0959-8049(16)31041-3

The Association between Glymphatic System and Perivascular Macrophages in Brain Waste Clearance.

Autor: Kaur, Jasleen^1,2 (AUTHOR) jkaur3@hfhs.org, Boyd, Edward D.^1,3 (AUTHOR) eboyd3@hfhs.org, Ding, Guangliang^1,3 (AUTHOR) gding1@hfhs.org, Zhang, Li^1,4 (AUTHOR) lzhang3@hfhs.org, Luo, Hao¹ (AUTHOR) hluo2@hfhs.org, Li, Qingjiang¹ (AUTHOR) qli1@hfhs.org, Li, Lian¹ (AUTHOR) lli2@hfhs.org, Wei, Min¹ (AUTHOR) mwei1@hfhs.org, Landschoot-Ward, Julie¹ (AUTHOR) jlandsc1@hfhs.org, Chopp, Michael^1,2,4,5 (AUTHOR) mchopp1@hfhs.org, Zhang, Zhenggang^1,4,5 (AUTHOR) zzhang1@hfhs.org, Jiang, Quan^1,2,3,5 (AUTHOR) qjiang1@hfhs.org

Publikováno v: Diagnostics (2075-4418). Apr2024, Vol. 14 Issue 7, p731. 19p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.